Interleukin-12 and interleukin-2-induced invariant natural killer T-cell cytokine secretion and perforin expression independent of T-cell receptor activation

被引:21
|
作者
Hou, RH
Goloubeva, O
Neuberg, DS
Strominger, JL
Wilson, SB
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Biostat, Boston, MA 02115 USA
关键词
D O I
10.1046/j.1365-2567.2003.01701.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human invariant natural killer (iNK) T cells expressing an invariant Valpha24-Jalpha15 T-cell receptor (TCR) are thought to be important regulators of autoimmunity and tumour surveillance. Two major subsets of iNK T cells, CD4(+) or CD4(-) CD8(-) are known to exist, but the in vivo importance of CD4 expression is unclear. Since interleukin-12 (IL-12) is a key iNK T-cell-activating cytokine, the effect of IL-12 plus or minus the T-cell growth factor IL-2 on a large panel of CD4(+) versus CD4- CD8- iNK T-cell clones was examined. Strikingly, IL-12 and IL-2 significantly activated iNK T cells to secrete IL-4, interferon-gamma and granulocyte-macrophage colony-stimulating factor, and up-regulated perforin expression in the absence of TCR stimulation. Furthermore, IL-2 and IL-12 treatment resulted in a preferential increase in apoptosis of CD4(-) CD8(-) clones. Thus, independent of TCR activation, IL-2 and IL-12 can directly activate iNK T cells and provide a selective advantage to the CD4(+) iNK T-cell population.
引用
收藏
页码:30 / 37
页数:8
相关论文
共 50 条
  • [1] RETRACTED: Dissociated expression of natural killer 1.1 and T-cell receptor by invariant natural killer T cells after interleukin-12 receptor and T-cell receptor signalling (Retracted Article)
    Emoto, Masashi
    Shimizu, Takamitsu
    Koike, Hiromi
    Yoshizawa, Izumi
    Hurwitz, Robert
    Kaufmann, Stefan H. E.
    Emoto, Yoshiko
    IMMUNOLOGY, 2010, 129 (01) : 62 - 74
  • [2] RETRACTION: Dissociated expression of natural killer 1.1 and T-cell receptor by invariant natural killer T cells after interleukin-12 receptor and T-cell receptor signalling (Retraction of Vol 129, Pg 62, 2010)
    Emoto, M.
    Shimizu, T.
    Koike, H.
    Yoshizawa, I
    Hurwitz, R.
    Kaufmann, S. H. E.
    Emoto, Y.
    IMMUNOLOGY, 2020, 161 (01) : 80 - 80
  • [3] Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin-12, and interleukin-2
    Rook, AH
    Kuzel, TM
    Olsen, EA
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2003, 17 (06) : 1435 - +
  • [4] Interaction of interleukin 15 with interleukin 12 and interleukin 10 in the regulation of T-cell activation and T cell derived cytokine production.
    Korholz, D
    Banning, U
    MauzKorholz, C
    Bonig, H
    KleinVehne, A
    Burdach, S
    BLOOD, 1996, 88 (10) : 1238 - 1238
  • [5] Interleukin-12 induces lesion regression and cytotoxic T-cell responses in cutaneous T-cell lymphoma
    Rook, A
    Vonderheld, E
    Yoo, E
    Kao, D
    Elenitsas, R
    Sherman, M
    Shane, R
    Lessin, S
    Wood, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (04) : 609 - 609
  • [6] INTERLEUKIN 1 AND T-CELL ACTIVATION
    CAMPOSNETO, A
    STASHENKO, PP
    IMMUNOLOGY TODAY, 1988, 9 (05): : 131 - 131
  • [7] A High-Avidity T-cell Receptor Redirects Natural Killer T-cell Specificity and Outcompetes the Endogenous Invariant T-cell Receptor
    Landoni, Elisa
    Smith, Christof C.
    Fuca, Giovanni
    Chen, Yuhui
    Sun, Chuang
    Vincent, Benjamin G.
    Metelitsa, Leonid S.
    Dotti, Gianpietro
    Savoldo, Barbara
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (01) : 57 - 69
  • [8] Choline deficient diet induced hepatosteatosis reduces hepatic Natural Killer (NK) T-cell numbers - role of Interleukin-12
    Kremer, M
    Hines, IN
    Milton, RJ
    Wheeler, MD
    FASEB JOURNAL, 2006, 20 (04): : A631 - A631
  • [9] Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses
    Rook, AH
    Wood, GS
    Yoo, EK
    Elenitsas, R
    Kao, DMF
    Sherman, ML
    Witmer, WK
    Rockwell, KA
    Shane, RB
    Lessin, SR
    Vonderheid, EC
    BLOOD, 1999, 94 (03) : 902 - 908
  • [10] Interleukin-12 induces lesion regression and cytotoxic T-cell responses in cutaneous T-cell lymphoma.
    Rook, AH
    Vonderheid, EC
    Yoo, EK
    Kao, DMF
    Elenitsas, R
    Niu, Z
    Sherman, ML
    Conlon, K
    Lessin, SR
    Wood, GS
    BLOOD, 1998, 92 (10) : 624A - 624A